Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$287.54
+3.26%
Mkt Cap $36.28B
Analyst Ratings
Buy
19
Hold
4
Sell
0
Price Target (69 analysts)
$454.27
Range $370.00 – $530.00
Implied Upside
+58.0%
Consensus $454.27 vs current $287.54